Shares of Brenntag AG (OTCMKTS:BNTGY - Get Free Report) have earned a consensus rating of "Reduce" from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $12.80.
A number of equities research analysts have recently weighed in on BNTGY shares. Barclays upgraded Brenntag to a "hold" rating in a research report on Thursday, January 15th. UBS Group upgraded Brenntag from a "sell" rating to a "neutral" rating in a research report on Thursday, April 30th.
View Our Latest Report on BNTGY
Brenntag Stock Down 0.9%
BNTGY stock opened at $14.52 on Thursday. The company has a market cap of $10.48 billion, a P/E ratio of 35.41 and a beta of 0.67. Brenntag has a twelve month low of $10.19 and a twelve month high of $14.97. The business has a fifty day moving average of $12.71 and a 200-day moving average of $12.09.
Brenntag (OTCMKTS:BNTGY - Get Free Report) last released its earnings results on Thursday, March 12th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of $0.24 by ($0.28). The firm had revenue of $4.09 billion for the quarter, compared to the consensus estimate of $4.22 billion. Brenntag had a return on equity of 5.89% and a net margin of 1.71%. As a group, equities research analysts anticipate that Brenntag will post 0.7 earnings per share for the current fiscal year.
Brenntag Company Profile
(
Get Free Report)
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Brenntag, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brenntag wasn't on the list.
While Brenntag currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.